| Tenofovir-based preexposure prophylaxis for HIV infection among African women JM Marrazzo, G Ramjee, BA Richardson, K Gomez, N Mgodi, G Nair, ... New England Journal of Medicine 372 (6), 509-518, 2015 | 1473 | 2015 |
| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 859 | 2016 |
| Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial S Skoler-Karpoff, G Ramjee, K Ahmed, L Altini, MG Plagianos, ... The Lancet 372 (9654), 1977-1987, 2008 | 605 | 2008 |
| PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial S McCormack, G Ramjee, A Kamali, H Rees, AM Crook, M Gafos, ... The Lancet 376 (9749), 1329-1337, 2010 | 392 | 2010 |
| Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003) J Marrazzo, G Ramjee, G Nair, T Palanee, B Mkhize, C Nakabiito, ... 20th Conference on Retroviruses and Opportunistic infections, 3-6, 2013 | 346 | 2013 |
| HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised … K Ahmed, JM Baeten, M Beksinska, LG Bekker, EA Bukusi, D Donnell, ... The Lancet 394 (10195), 303-313, 2019 | 206 | 2019 |
| An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women JE Balkus, E Brown, T Palanee, G Nair, Z Gafoor, J Zhang, BA Richardson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (3), 333-343, 2016 | 160 | 2016 |
| Acceptability and use of a dapivirine vaginal ring in a phase III trial ET Montgomery, A van der Straten, M Chitukuta, K Reddy, K Woeber, ... Aids 31 (8), 1159-1167, 2017 | 107 | 2017 |
| Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial S Delany-Moretlwe, C Lombard, D Baron, LG Bekker, B Nkala, K Ahmed, ... The Lancet infectious diseases 18 (11), 1241-1250, 2018 | 97 | 2018 |
| Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95, 2021 | 79 | 2021 |
| Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study LM Noguchi, BA Richardson, JM Baeten, SL Hillier, JE Balkus, ... The lancet HIV 2 (7), e279-e287, 2015 | 60 | 2015 |
| Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial ER Brown, CW Hendrix, A van der Straten, FM Kiweewa, NM Mgodi, ... Journal of the International AIDS Society 23 (11), e25634, 2020 | 58 | 2020 |
| Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa J Stadler, S Delany-Moretlwe, T Palanee, H Rees Social Science & Medicine 110, 49-55, 2014 | 58 | 2014 |
| Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel BS Mensch, PC Hewett, S Abbott, J Rankin, S Littlefield, K Ahmed, ... AIDS and Behavior 15, 407-421, 2011 | 54 | 2011 |
| Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa G Ramjee, N Coumi, N Dladla-Qwabe, S Ganesh, S Gappoo, R Govinden, ... AIDS research and therapy 7, 1-12, 2010 | 54 | 2010 |
| Age-disparate partnerships and risk of HIV-1 acquisition among South African women participating in the VOICE trial JE Balkus, G Nair, ET Montgomery, A Mishra, T Palanee-Phillips, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 212-217, 2015 | 51 | 2015 |
| Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection E Brown, T Palanee-Philips, M Marzinke, C Hendrix, C Dezutti, ... Journal of the International Aids Society 19, 2016 | 46 | 2016 |
| Impact of male partner involvement on women’s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial ST Roberts, G Nair, JM Baeten, T Palanee-Philips, K Schwartz, K Reddy, ... AIDS and Behavior 24, 1432-1442, 2020 | 42 | 2020 |
| Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a phase III trial T Palanee-Phillips, ST Roberts, K Reddy, V Govender, L Naidoo, S Siva, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (5), 580-589, 2018 | 40 | 2018 |
| MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu‐Natal, South Africa PK Chelule, M Gordon, T Palanee, T Page, A Mosam, HM Coovadia, ... Clinical Pharmacology & Therapeutics 74 (2), 195-196, 2003 | 39 | 2003 |
